2022-07-12
What are the effects of reshoring the generic active pharmaceutical ingredient (API) manufacturing on the medicine availability in Europe?
Publication
Publication
| Additional Metadata | |
|---|---|
| , , | |
| Lemmens, Stef, de Vries, Harwin | |
| hdl.handle.net/2105/63645 | |
| Supply Chain Management | |
| Organisation | Rotterdam School of Management |
|
Nguyen, Ngoc. (2022, July 12). What are the effects of reshoring the generic active pharmaceutical ingredient (API) manufacturing on the medicine availability in Europe?. Supply Chain Management. Retrieved from http://hdl.handle.net/2105/63645 |
|